Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
The closing of the business combination with PowerUp Acquisition Corp. creates Nasdaq-listed biopharmaceutical company dedicated to developing ...
ETF Daily News15d
AtriCure, Inc. (NASDAQ:ATRC) Receives $43.38 Average Price Target from Analysts
A number of research firms recently issued reports on ATRC. Oppenheimer increased their target price on AtriCure from $32.00 to $36.00 and gave the stock an “outperform” rating in a research ...
Nasdaq15d
Will AtriCure (ATRC) Report Negative Earnings Next Week? What You Should Know
Wall Street expects a year-over-year increase in earnings on higher revenues when AtriCure (ATRC) reports results for the quarter ended December 2024. While this widely-known consensus outlook is ...
Business Insider15d
Aspire North Launches Aspire Data Network Utilizing Experian Marketing Data
NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Aspire North, in collaboration with Experian Marketing Services (EMS), has announced the launch of the Aspire Data Network (ADN). This self-service ...
Yahoo Finance17d
AtriCure, Inc. (ATRC)
MASON, Ohio, January 22, 2025--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management ...
Zawya18d
ATRC marks UAE Innovation Month 2025 by empowering researchers and the next generation in advanced technology
Abu Dhabi, UAE: The Advanced Technology Research Council (ATRC), mandated to shape an advanced R&D ecosystem in Abu Dhabi and drive the nation’s strategic research priorities, is not only turning ...
morningstar.com.au23d
AtriCure Inc
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to ...